SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Taking Advantage of a Sharply Changing Environment -- Ignore unavailable to you. Want to Upgrade?


To: Doug R who wrote (2903)1/31/2020 7:50:09 AM
From: 3bar  Respond to of 6337
 
Great chart , says it ! Of an interesting note the reason the cr was 67% and not 100 . One patient had cancer metastasized to their bones and had to be removed from the trial .

They only needed 3 for this phase 1 as the compound is like a food to human cells almost benign . They just wanted to know if the compound would be tolerated .

Results were over the top and out of the park .